EUVIMEDEUVIMED entdecken
Crossref

Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing

Jen Ghabrial, Victoria Stinnett, Efrain Ribeiro, Melanie Klausner, Laura Morsberger, Patty Long, William Middlezong, Rena Xian, Christopher Gocke, Ming-Tseh Lin, Lisa Rooper, Ezra Baraban und 5 weitere

Modern Pathology · 2025-04 · 38 (4) · 100684

DOI: 10.1016/j.modpat.2024.100684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Jen Ghabrial und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Soft Tissue Neoplasms, Bone Neoplasms, High-Throughput Nucleotide Sequencing, Chromosome Mapping. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Detecting somatic structural variants (SVs), copy number variants (CNVs), and mutations in bone and soft tissue tumors is essential for accurately diagnosing, treating, and prognosticating outcomes. Optical genome mapping (OGM) holds promise to yield useful data on SVs and CNVs but requires fresh or snap-frozen tissues. This study aimed to evaluate the clinical utility of data from OGM compared with current standard-of-care cytogenetic testing. We evaluated 60 consecutive specimens from bone and soft tissue tumors using OGM and karyotyping, fluorescence in situ hybridization, gene fusion assays, and deep next-generation sequencing. OGM accurately identified diagnostic SVs/CNVs previously detected by karyotyping and fluorescence in situ hybridization (specificity = 100%). OGM identified diagnostic and pathogenic SVs/CNVs (∼23% of cases) undetected by karyotyping (cryptic/submicroscopic). OGM allowed the detection and further characterization of complex structural rearrangements including chromoanagenesis (27% of cases) and complex 3- to 6-way translocations (15% of cases). In addition to identifying 321 SVs and CNVs among cases with chromoanagenesis events, OGM identified approximately 9 SVs and 12 CNVs per sample. A combination of OGM and deep next-generation sequencing data identified diagnostic, disease-associated, and pathogenic SVs, CNVs, and mutations in ∼98% of the cases. Our cohort contained the most extensive collection of bone and soft tissue tumors profiled by OGM. OGM had excellent concordance with standard-of-care cytogenetic testing, detecting and assigning high-resolution genome-wide genomic abnormalities with higher sensitivity than routine testing. This is the first and largest study to provide insights into the clinical utility of combined OGM and deep sequencing for the pathologic diagnosis and potential prognostication of bone and soft tissue tumors in routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soft Tissue NeoplasmsBone NeoplasmsHigh-Throughput Nucleotide SequencingChromosome MappingBiomarkers, TumorHumansFemaleMaleMiddle AgedAdultAgedYoung AdultPrognosisAdolescentDNA Copy Number VariationsChildAged, 80 and overIn Situ Hybridization, FluorescenceKaryotypingMutation

Stichwörter der Autor:innen

bone and soft tissue tumorscopy number variantsgene fusionsmutationsnext-generation sequencingoptical genome mapping

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Molecular and Cellular Biology, Johns Hopkins University, Baltimore, Maryland.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: jgross28@jhmi.edu.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: yzou19@jhmi.edu.

Zitieren

APA

Ghabrial, J., Stinnett, V., Ribeiro, E., Klausner, M., Morsberger, L., Long, P., Middlezong, W., Xian, R., Gocke, C., Lin, M. T., Rooper, L., Baraban, E., Argani, P., Pallavajjala, A., Murry, J. B., Gross, J. M., & Zou, Y. S. (2025). Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing. Modern Pathology, 38(4), 100684. https://doi.org/10.1016/j.modpat.2024.100684

Vancouver

Ghabrial J, Stinnett V, Ribeiro E, Klausner M, Morsberger L, Long P, et al. Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing. Modern Pathology. 2025;38(4):100684. doi:10.1016/j.modpat.2024.100684

BibTeX
@article{Ghabrial2025,
  author = {Ghabrial, Jen and Stinnett, Victoria and Ribeiro, Efrain and Klausner, Melanie and Morsberger, Laura and Long, Patty and Middlezong, William and Xian, Rena and Gocke, Christopher and Lin, Ming-Tseh and Rooper, Lisa and Baraban, Ezra and Argani, Pedram and Pallavajjala, Aparna and Murry, Jaclyn B and Gross, John M and Zou, Ying S},
  title = {Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {4},
  pages = {100684},
  doi = {10.1016/j.modpat.2024.100684}
}
Kostenlos starten →